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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYPathogenic de novo mutations increase with fathers’ age and could be amplified through competition between genetically distinct
subpopulations of spermatogonial stem cells (SSCs). Here, we tested the fitness of SSCs bearing wild-type human FGFR2 or an Apert syn-
drome mutant, FGFR2 (S252W), to provide experimental evidence for SSC competition. The S252W allele conferred enhanced FGFR2-
mediated signaling, particularly at very low concentrations of ligand, and also subtle changes in gene expression. Mutant SSCs exhibited
improved competitiveness in vitro and increased stem cell activity in vivo upon transplantation. The fitness advantage in vitro only
occurred in low concentrations of fibroblast growth factor (FGF), was independent of FGF-driven proliferation, and was accompanied
by increased response to glial cell line-derived neurotrophic factor (GDNF). Our studies provide experimental evidence of enhanced
stem cell fitness in SSCs bearing a paternal age-associatedmutation. Ourmodel will be useful for interrogating other candidatemutations
in the future to reveal mechanisms of disease risk.INTRODUCTION
Cell-to-cell competition among male germline stem cells
has been proposed to account for the higher frequency of
some disorders among children of older fathers, a correla-
tion referred to as the paternal age effect (PAE) (Goriely
and Wilkie, 2012). In addition to compelling observations
in humans, evidence of male germline selection was noted
in early mammalian models of genetic mosaicism (Jae-
nisch, 1976). However, the mechanism of positive selec-
tion for PAE mutations has not been directly interrogated
in an experimental stem cell model.
Consistent with a role of germline selection, landmark
studies correlated increasing numbers of pathogenic alleles
with men’s age either in sperm or in microanatomical clus-
ters in the normal testis (Choi et al., 2008; Goriely et al.,
2003). The observed rise in mutant allele frequency was
above that which could be explained by alternate hypoth-
eses (e.g., mutational hot spots) and was attributed to pos-
itive selection of mutant spermatogonial stem cells (SSCs),
which represent the only long-lived germ cell in the
mammalian testis. This provocative concept has been
referred to as the selfish selection hypothesis (Goriely and
Wilkie, 2012).
Several factors are crucial for SSC maintenance in mam-
mals. Among these, glial cell line-derived neurotrophic fac-
tor (GDNF), secretedbySertoli cells, binds to theRET/GFRa1
receptor complex, providing a critical signal for SSC survival
(Menget al., 2000). Seminal studies that establishedSSCcul-
ture conditions identified additional niche-derived growth
factors (e.g., fibroblast growth factor [FGF] and epidermal
growth factor [EGF]) that support maintenance of SSCsStem Cin vitro (Kubota et al., 2004). While genetic models deter-
mined that GDNF is essential, the effects of other growth
factors in SSC fate decisions remain largely unclear.
Several signaling pathways and unique transcriptional
programsare thought to control SSCself-renewal anddiffer-
entiation in mammals. Transcriptional regulators typically
associated with SSC self-renewal include Plzf, Etv5, Bcl6b,
Pou3f1, Lhx1, and Foxo1 (Buaas et al., 2004; Costoya et al.,
2004; Goertz et al., 2011). GDNF induces Etv5, Bcl6b, and
Pou3f1 (Oatley et al., 2006). Etv5 and Foxo1 induce Ret
expression, establishing a positive feedback mechanism
for GDNF signaling to maintain self-renewal. FGF2 also in-
creases the expression of Etv5 through mitogen-activated
protein kinase (MAPK) activation, contributing to SSC
self-renewal, at least in part by increasing GDNF/RET
signaling (Ishii et al., 2012). Additionally, activation of the
AKT and MAPK signaling pathways by GDNF and FGF2
were correlated with SSC maintenance (Lee et al., 2007).
While SSC self-renewal requires growth factor signaling,
previous studies have found that stem cell activity is
impaired in the presence of excess FGF- or EGF-mediated
signaling (Kubota et al., 2004). Moreover, excessive self-
renewal signals induce oncogenic transformation and
impair SSC maintenance (Goertz et al., 2011; Lee et al.,
2009). In contrast, gain-of-function (GOF) mutations in
fibroblast growth factor receptor 2 (FGFR2), associated
with enhanced FGF signaling, are the basis for Apert syn-
drome, in which the PAE is particularly robust (Choi
et al., 2008). Furthermore, other disorders that exhibit a
strong PAE (e.g., achondroplasia and MEN2B) are due to
mutant alleles that also increase growth factor signaling
in affected organs and tissues (Goriely and Wilkie, 2012).ell Reports j Vol. 3 j 219–226 j August 12, 2014 j ª2014 The Authors 219
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Figure 1. Expression of FGFR2 in Human Testis and in
Mouse SSCs
(A) IHC with tyramide signal amplification (TSA) on adult human
testis, showing positive reactivity (reddish brown; arrows) to
monoclonal anti-human FGFR2 antibody exclusively in spermato-
gonia along the basement membrane (inset, mouse IgG; scale bar,
100 mm).
(B) qRT-PCR showing FGFR2 expression levels in human testis from
young (17–25 years; mean ± SD, n = 3 donors) and older (49–62
years; mean ± SD, n = 5 donors) cohorts.
(C) Relative Fgfr2 expression in SSC lines compared to mouse testis
(mTestis) using primers annealing in the extracellular (ECD) and
the kinase domains, respectively (mean ± SD; n = 3 biological
replicates).
(D) Immunostaining with TSA (green) in cultured mouse SSC
cytospin preparations showing endogenous FGFR2 protein expres-
sion with two different monoclonal antibodies (moAb) (scale bar,
25 mm)
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Mutant FGFR2 Enhances Fitness of SSCsHence, the selfish spermatogonial selection hypothesis
presents a conundrum, since balanced signaling (i.e.,
through AKT and MAPK) seems necessary for SSC mainte-
nance (Kanatsu-Shinohara and Shinohara, 2013). The
aim of this study is to provide direct experimental evidence
for the PAEmechanism in Apert syndrome and to reconcile
how activating mutations could improve stem cell fitness.
To this end, we constructed a model system with adult
mouse SSCs. Both in long-term culture and upon trans-
plantation into recipient mice, we demonstrate that a
human Apert syndrome allele confers enhanced fitness to
SSCs, concomitant with increased downstream signals
that support self-renewal of SSCs.RESULTS
Expression of FGFR2 in Human Testis and Adult
Mouse SSCs
FGFR2 mutations (e.g., S252W) in Apert syndrome accu-
mulate in the testes of older men (Goriely et al., 2003).
However, previous studies did not establish FGFR2 protein
distribution in spermatogonia. When we attempted to
localize FGFR2 using conventional immunostaining, no
signal was observed (data not shown). Then, by using
the highly sensitive tyramide signal amplification (TSA)
approach, anti-FGFR2 monoclonal immunoreactivity was
detected adjacent to the basement membrane in the
human testis, consistent with the known location of sper-
matogonia. No reactivity was observed in differentiated
germ cells or Sertoli cells (Figure 1A). We next evaluated
the expression of FGFR2 in the human testis by quantita-
tive RT-PCR (qRT-PCR). FGFR2 was detected at the mRNA
level in samples of normal adult human testis across a
wide age range (17–62 years; Figure 1B).
To confirm that mouse SSCs represent a good model in
which to address the PAE mechanism in Apert syndrome,
SSCs in long-term culturewere tested for FGFR2 expression.
We had previously derived primary SSC lines from adult
mice and confirmed their stem cell activity in vivo (Martin
and Seandel, 2013; Seandel et al., 2007). Expression of
FGFR2 was found by both qRT-PCR and immunofluores-
cence (IF) with TSA in several independently derived SSC
lines (Figures 1C and 1D). Taken together, these data sug-
gest that FGFR2 is normally expressed in the mammalian
testis, albeit at low levels, in cell populations that could
propagate a long-term clonal effect. Based on this, we
used mouse SSC lines to address the cellular mechanism
of the FGFR2-mediated PAE.Ectopic Expression of hFGFR2 Alleles in Mouse SSCs
To test the selfish selection hypothesis experimentally and
assess fitness of wild-type (WT) versus mutant SSCs, wehors
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Figure 2. Delivery of Ectopic Human FGFR2 Alleles in Adult Mouse SSCs
(A) Schematic of FGFR2 protein and primers for human-specific FGFR2 qRT-PCR. Asterisk marks the location of the S252W Apert mutation
(ECD, extracellular domain).
(B) qRT-PCR using two sets of primers showing relative expression levels of hFGFR2 in lentivirus-transduced SSCs bearing WT hFGFR2 (WT)
or human S252W FGFR2 (S252W) with untransduced SSCs as the reference control (mean ± SD of three independent cell lines per
genotype).
(C) IF on cytospins (top row) with anti-hFGFR2 antibody (green) for SSCs stably expressing WT (middle) or S252W (right) alleles and
untransduced SSCs as control (left). Scale bar, 10 mm. Phase contrast (bottom row) of untransduced SSCs (control; left) or stably expressing
hFGFR2 WT (middle) or S252W (right) alleles in standard culture conditions (scale bar, 50 mm).
(D) Immunoprecipitation (IP) and detection with two specific monoclonal antibodies for hFGFR2 in WT and S252W SSC. Controls:
untransduced SSCs and JK1 feeder cells or 293T cells transduced with WT or S252W lentiviruses. Grey dashed line denotes cropped lane.
See also Figure S1.
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Mutant FGFR2 Enhances Fitness of SSCsgenerated adult mouse SSCs stably expressing WT human
FGFR2 or the PAE-associated FGFR2 S252W Apert syn-
dromemutation (referred to asWTor S252WhFGFR2 here-
after) by transduction with lentiviruses. Expression levels
of hFGFR2 in each SSC line were measured by qRT-PCR
with specific primers for the human gene (Figures 2A and
2B). Human FGFR2 protein expression in SSCs was
compared by IF and immunoprecipitation followed by
immunoblot (IB) with monoclonal antibodies that specif-
ically recognize hFGFR2, confirming similar expression
levels for both hFGFR2 alleles and equivalent cellular distri-
bution (Figures 2C and 2D).
Potential mechanisms that would result in a selective
advantage to different clonal cell populations within
a given environment include enhanced proliferative
capacity or survival. We compared each of these parame-
ters in WT and S252W SSCs by measuring expansion of
cell populations over time, mitotic fraction, apoptosis,
and also cell adhesion. No significant differences were
found between the two cell populations (Figures S1A–Stem CS1D available online). Next, we asked whether alterations
in the frequency of asymmetric (i.e., differentiating) cell
divisions could change the ratio of WT versus mutant
spermatogonia. As a surrogate for differentiation capacity,
we tested the response of WT and mutant SSCs to
retinoic acid (RA), shown previously to initiate sper-
matogonial differentiation in vitro in a physiologically
relevant manner (Dann et al., 2008). Both cell popula-
tions responded appropriately to RA exposure by upre-
gulating genes associated with differentiation and down-
regulating stem cell-associated genes (Figure S1E). To
determine whether the stem cell phenotype per se could
mediate the PAE observed in Apert syndrome, we sur-
veyed expression levels of genes associated with self-
renewal and differentiation in WT versus S252W SSCs
(Figures S1F–S1H). Although consistent differences in
expression of most genes were not seen, we did find mark-
edly higher expression of Etv5, a critical transcription fac-
tor for SSC maintenance, in S252W SSCs (Oatley et al.,
2006).ell Reports j Vol. 3 j 219–226 j August 12, 2014 j ª2014 The Authors 221
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Figure 3. Enhanced Sensitivity of S252W
SSCs to FGF
(A) Representative anti-p42/44 MAPK
(pErk1/2) IB in WT and S252W SSCs in
response to FGF2 doses (0.05 and 0.25 ng/ml).
Grey dashed line denotes cropped lane. Graphs
correspond to densitometric analyses of IB
image above for pErk1/2, normalized to
loading control (GADPH), with values shown
for each condition in arbitrary units (A.U.).
(B and C) Proliferation curves showing WT and
S252W SSC numbers (mean ± SD; n = 3 wells/
condition) after 2–4 weeks in vitro with either
(B) reduced FGF2 (1 ng/ml) or (C) reduced
GDNF (doses shown) and reduced FGF2
(1 ng/ml). Curves correspond to two biolog-
ical replicates. Bar graph in (B) depicts fold
change in total cell number of S252W versus
WT SSCs at indicated time points in three
biological replicates (mean ± SD).
See also Figure S2.
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Mutant FGFR2 Enhances Fitness of SSCsS252W SSCs Exhibit Enhanced Sensitivity to Growth
Factors
Our preliminary characterization of the hFGFR2 SSC lines
suggested a mechanism of autonomously increased self-
renewal potential of S252W SSCs. However, relatively little
is known about how FGFR2-mediated signaling affects SSC
self-renewal. Previous studies in other cellular contexts
have demonstrated that the S252W FGFR2 mutant recep-
tor exhibits decreased ligand dissociation (Anderson
et al., 1998). Accordingly, we compared pMAPK and also222 Stem Cell Reports j Vol. 3 j 219–226 j August 12, 2014 j ª2014 The AutpAKT levels in WT and S252W SSCs upon FGF2 stimula-
tion. While no consistent differences were detected at
R0.5 ng/ml FGF2 (data not shown), S252W SSCs yielded
greater pMAPK and, to a more moderate extent, greater
pAKT at lower FGF2 concentrations than WT cells (Figures
3A and S2A). Notably, in the presence of reduced FGF2
(1 ng/ml), there was no difference in the proliferation of
the two cell variants (Figure 3B).
Based on our observations with hFGFR2 SSCs, we interro-
gated the effect of FGF dose on downstream signalinghors
Stem Cell Reports
Mutant FGFR2 Enhances Fitness of SSCsthrough endogenous FGF receptors. Low doses of FGF2
induced pMAPK and pAKT and loss of pStat3 (Figures
S2B–S2D). However, higher doses of FGF2 reversed this
effect. In contrast, GDNF induced a dose-dependent in-
crease in pMAPK and pAKT (Figures S2E and S2F). To test
the sustained effects FGF2, we profiled SSCs at varying
chronic doses (0–10 ng/ml) and found an inverse relation-
ship of FGF dose and expression levels for certain stem cell
markers (i.e., Id4, Etv5, and Sall4), while other markers (Ret,
Pou3F1, Lhx1, and Kit) did not change (Figures S2G and
S2I). These data are generally concordant with a previous
study using a different culture system, which showed that
SSCs maintained at a relatively low FGF2 dose exhibit
higher colonization activity, compared to SSCs cultured
with higher doses of FGF2 (Kubota et al., 2004).
Based on the increased responsiveness of S252W SSCs to
FGF (Figures 3A and S2A), we asked next whether enhanced
FGFR2 signaling could alleviate the requirement for GDNF.
To test this possibility, WT and S252W SSCs were cultured
in reduced FGF2 and GDNF concentrations. Compared to
WT SSCs, S252W SSCs exhibited increased cell recovery
under these conditions and were able to overcome a sub-
standard GDNF concentration (Figure 3C). Collectively,
these results suggest that the Apert S252W mutation en-
ables SSCs to withstand the potentially detrimental effects
of reduced growth factors in the niche.
Competition between WT and S252W SSCs
Our data above suggest an increased self-renewal capability
of S252W SSCs, particularly when growth factors are
limited. However, the selfish selection hypothesis proposes
a competition-based mechanism (Goriely and Wilkie,
2012). Thus, we asked next whether the Apert S252Wmu-
tation confers higher functional stem cell activity and a
selective advantage that enables mutants to outcompete
WT counterparts. To this end, differentially labeled WT
and S252W SSCs expressing GFP or mCherry, respectively,
were cocultured in vitro for several weeks or mixed imme-
diately prior transplantation as shown in Figure 4A.
For in vitro evaluation, differentially labeled populations
were mixed in the presence of varying FGF concentrations
to impose a selective pressure. Changes in the S252W-to-
WTratio weremeasured serially by flow cytometry (fluores-
cence-activated cell sorting [FACS]; Figures 4B and S3C, and
S3D). After several weeks of coculture, S252W-expressing
SSCs progressively outcompeted WT cells independently
of the initial mixing ratio and became the predominant
population in the culture. Of note, this difference was
only observed in the presence of reduced FGF conditions,
but not in standard culture media (Figures 4B and S3A).
We next assessed stem cell activity of cultured WT and
S252W SSCs in vivo by transplantation into busulfan-
treated mice. Differentially labeled WT and S252W SSCsStem Cwere mixed immediately prior to transplantation into the
testis. GFP+ andmCherry+ colonies were counted 2months
after surgery, revealing that mutant cells exhibited signifi-
cantly greater stem cell activity than WT (Figure 4C).
Similar results were obtained when GFP and mCherry
labels were reversed, excluding intrinsic effects of the label-
ing system. In an alternate experimental design, the two
populations were mixed and cocultured in vitro for several
weeks prior to transplantationwith similar results (data not
shown). Collectively, these data demonstrate that the
S252W PAE mutation confers a fitness advantage to SSCs.DISCUSSION
The selfish spermatogonia selection hypothesis proposes
that pathogenic alleles in human PAE disorders become en-
riched through clonal expansion of mutant SSCs that
possess an acquired competitive advantage (Goriely and
Wilkie, 2012). Here, we modeled stem cell fitness prospec-
tively to address the effects of a PAE-associated hFGFR2mu-
tation in adult SSCs. In vitro cell competition data together
with cotransplantation constitute the only experimental
evidence to date for increased fitness and stem cell activity
of mutant S252W SSCs over WT.
Cell competition in adults plays a role in organ homeo-
stasis; for example, germline stem cells in Drosophila
continuously compete for niche occupancy (Zhao and Xi,
2010). To some extent, stem cell replacement occurs in a
stochastic manner (Klein et al., 2010). However, sporadi-
cally occurring mutations during aging or certain patho-
logical processes (e.g., cancer) can influence stem cell
dynamics. The competitive advantage of tumor cell sub-
clones provides a compelling analogy for the PAE mecha-
nism proposed here and elsewhere (Goriely and Wilkie,
2012). Even so, several features differ. First, tumor cells do
not retain their full differentiation capacity or function-
ality as differentiated cells. Our data show that mutant
SSCs are capable of responding to RA similar to WT cells
in vitro, suggesting that early differentiation is unaffected.
Also, our studies did not detect marked differences in FGF-
mediated proliferation or survival of SSCs in vitro, even
under media conditions in which a competitive advantage
was observable. On the other hand, mutant cells exhibit
increased expression of Etv5, a critical transcription factor
to maintain SSCs, implying some level of intrinsically
elevated self-renewal capability of mutant cells over WT.
Also intriguing is the minimal overlap between the spec-
trum of acquired mutations in the most common forms of
testicular cancer and the congenital variants observed in
PAE disorders. In addition to Apert syndrome alleles,
other pathogenic mutations, including those in RET and
PTPN11, exhibit both a strong PAE and evidence of clonalell Reports j Vol. 3 j 219–226 j August 12, 2014 j ª2014 The Authors 223
Figure 4. Enhanced Stem Cell Fitness of S252W SSCs
(A) Schematic of mixing experiments to assess fitness of WT versus
S252W SSCs. For in vitro experiments, differentially labeled WT and
mutant SSCs were mixed and cultured with different doses of FGF2.
Stem cell activity was measured by transplantation into busulfan-
treated mice. Two months after transplantation, the number of GFP
and mCherry colonies in each testis was counted.
(B) In vitro mixing experiment showing a significant change over
time in the ratio (FACS) of cocultured S252W and WT SSCs in
reduced FGF2 (1 ng/ml), for both 1:1 and 1:2 starting ratios. Curves
correspond to one representative biological replicate and show the
mean (±SD; n = 3 wells/time point). Fluorescent images show
mixed SSC colonies (scale bar, 50 mm). Bar graphs show the starting
(i.e., measured postplating) and final ratios in three biological
replicates. Error bars correspond to ±SD; n = 3 wells/time point.
(C) Top: representative transplantation experiment showing colony
quantification for each genotype in transplanted testes (n = 14)
with mixed WT-GFP and S252W-mCherry SSCs. ***p < 0.005 (Wil-
coxon matched-pairs signed rank test). Fluorescent images: a
transplanted testis with WT (green) and mutant (red) colonies
(arrows; dashed line denotes testis border; scale bar, 1 mm) (top
image), and representative WT (green) and S252W (red) colony
detail (scale bars, 200 mm) (bottom images). Bottom: pooled
transplant data (n = 10 experiments, 77 testes) showing the
normalized percentage of colonies of each genotype per testis.
See also Figure S3.
224 Stem Cell Reports j Vol. 3 j 219–226 j August 12, 2014 j ª2014 The Aut
Stem Cell Reports
Mutant FGFR2 Enhances Fitness of SSCsexpansion of SSCs (Yoon et al., 2013). However, most PAE
mutations documented to date are weakly acting, consis-
tent with the idea that excessive upstream signal is delete-
rious to self-renewal. Indeed, we found diminished pMAPK
and pAKT but increased pSTAT3 when SSCs were exposed
to high FGF2. This finding also fits with the decreased
SSC colonization observedwhen SSC are cultured in higher
FGF or EGF doses (Kubota et al., 2004). Accordingly, S252W
SSCs exhibited increased sensitivity to low FGF2 doses, as
evidenced by slightly enhanced downstream signaling
(i.e., through MAPK and AKT), compared to WT SSCs.
Taken together, these data could provide a further explana-
tion for why only mild GOF mutations are typically found
in congenital disorders, as opposed to strongly activating
somatic mutations in tumorigenesis.
Enhanced downstream signaling could confer resistance
to a suboptimal niche. Strikingly, a recent study in a model
of intestinal tumorigenesis showed that stem cells bearing
activating mutations only acquired an advantage in a dete-
riorated niche (Vermeulen et al., 2013). In fact, we observed
an in vitro advantage for mutants in low FGF2 conditions
only. However, the finding that mutant SSCs grown in
standard, high growth factor media still exhibited higher
stem cell activity at transplant suggests that the FACS-based
metric of fitness in vitro may be less sensitive than the
transplant-based readout. Also, it is certain that the culture
milieu does not perfectly recapitulate the stem cell niche
in vivo. Unexpectedly, our data also show that mutanthors
Stem Cell Reports
Mutant FGFR2 Enhances Fitness of SSCsSSCs can be maintained even when GDNF is limiting.
Finally, previous studies revealed decreased expression of
critical SSC growth factors, such as GDNF and FGF2, during
normal aging and an age-related decline in niche function
(Ryu et al., 2006). Taken together, these findings suggest
that niche-dependent signaling in the mammalian testis
must undergo exquisite regulation to avoid stem cell loss.
Therefore, slight changes in the microenvironment could
have profound effects on cell phenotype, such that other-
wise neutral genotypes become beneficial under stressful
conditions or with aging.
Other cell-extrinsic mechanisms may lead to a progres-
sive loss of WT cells through an active process that
eliminates the least fit populations. Such processes occur
during normal development in the mammalian embryo,
in which relatively unfit populations are deleted through
apoptosis (Claverı´a et al., 2013). At present, we cannot
exclude the possibility that active elimination of WT cells
contributes to selection of FGFR2 S252Wmutants. Perhaps
the degree of PAE observed in different disorders reflects
diverse mechanisms of stem cell competition occurring in
the testis.
While the association between paternal age and risk
monogenic disorders was observed >100 years ago, a
variety of recent evidence has implicated de novo muta-
tions in complex disorders, such as autism and schizo-
phrenia (Goriely and Wilkie, 2012). We speculate that a
subset of such mutations become enriched by a similar
mechanism as in Apert syndrome. Therefore, in a society
of increasingly older fathers, a relatively large swath of dis-
ease risk could originate in SSCs, even if the absolute in-
crease in risk due to paternal age for any one disorder is
low (Martin et al., 2010). For these reasons, it will be essen-
tial to more thoroughly elucidate the common mecha-
nisms (or divergent pathways) that lead to SSC competition
in subsequent studies.EXPERIMENTAL PROCEDURES
SSC Culture
SSC lines were derived from C57Bl6/129S adult mice and main-
tained on mitotically inactivated JK1 feeder cells as previously
described (Martin and Seandel, 2013). StemPro-34 containing
20 ng/ml GDNF, 10 ng/ml FGF2, 20 ng/ml EGF, and 25 mg/ml insu-
lin was used for SSC culture (Seandel et al., 2007). SSC lines stably
expressing hFGFR2 alleles and GFP or mCherry were generated by
lentivirus. Feeder-free SSCs were treated with 1 mM RA or vehicle
control for 72 hr (Dann et al., 2008). For cytokine stimulation,
feeder-free SSCs were starved overnight and stimulated for
20 min with growth factors. Experiments were performed at least
twice using SSC lines derived from different mice. For in vitro
competition, mixed, differentially labeled WT and S252W SSCs
were plated in triplicate and cocultured for several weeks in FGF2
(0.2–10 ng/ml). The mutant-to-WT ratio was determined seriallyStem Cby FACS (Accuri C6). All mouse experiments were performed in
accordance with institutional and national guidelines and regula-
tions including the Weill Cornell Medical College Institutional
Animal Care and Use Committee.
SSC Transplantation
SSC transplant assays were performed as described previously
using busulfan-conditioned mice (Seandel et al., 2007). Differen-
tially labeled WT and S252W SSCs were mixed immediately prior
to transplantation or first cocultured in vitro for several weeks.
Two months later, detunicated recipient testes were analyzed for
GFP+ or mCherry+ colonies and quantified using a fluorescent
stereoscope (Zeiss).
Immunodetection
Human cadaver testis tissue was obtained from the New York
OrganDonorNetwork (Sachs et al., 2014).Whereas IHC for endog-
enous FGFR2 in human tissue and SSC lines required TSA, detec-
tion of ectopic human FGFR2 was performed using standard
biotin-conjugated secondary antibodies and streptavidin-fluoro-
phore conjugates as detailed in the Supplemental Experimental
Procedures. FGFR2 was detected using two different monoclonal
anti-human FGFR2 antibodies (ab119237, Abcam; and sc-6930,
Santa Cruz Biotechnology). Phospho-histone 3 serine10 (PH3)
was detected with anti-PH3 (Millipore 06-570). Immunoprecipita-
tionwas performed using protein lysates from feeder-free SSCs and
anti-human FGFR2 rabbit monoclonal antibody (D4H9, Cell
Signaling). Immunoblot was performed with anti-human FGFR2
antibody (ab119237, Abcam). Detailed methods are found in the
Supplemental Experimental Procedures.
For more information, please refer to Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and three figures and can be found with this article
online at http://dx.doi.org/10.1016/j.stemcr.2014.06.007.
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